Portfolio company
Ona Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
7 investors
Sectors
About
This company develops antibody-drug conjugates to treat patients with advanced and metastatic cancers which have become resistant to existing therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ImmunoQuest Therapeutics
This preclinical biopharmaceutical company develops antibody-drug conjugates for patients with treatment-resistant, metastatic breast cancer and other solid tumours.
Emergence Therapeutics
This biopharmaceutical company develops antibody-drug conjugate immunotherapies to treat solid tumours for patients with high unmet medical needs.
Adcytherix
This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.
Adcendo
This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.
TORL BioTherapeutics
This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Alphina Therapeutics
This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.
Tizona Therapeutics
This biopharmaceutical company develops first-in-class cancer immunotherapies and antibody-based treatments for patients with advanced solid tumours.
